Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Truqap
Pharma
AZ's Truqap carves path in prostate cancer with phase 3 win
The AKT inhibitor's early win in a prostate cancer subtype follows a recent surprise flop in a breast cancer study.
Zoey Becker
Nov 25, 2024 11:12am
Roche burnishes breast cancer portfolio with FDA nod for Itovebi
Oct 10, 2024 5:30pm
AstraZeneca stands by Truqap despite surprise breast cancer flop
Sep 13, 2024 10:00am
AZ's Truqap came up short in triple-negative breast cancer study
Jun 18, 2024 9:09am
AZ's first-in-class breast cancer approval marred by restriction
Nov 17, 2023 11:02am
